Skip to content
Close
SEARCH
CONTACT US
CONTACT US

OUR SERVICES

We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.

VIEW ALL SERVICES
PHASES
DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
CLINICAL DEVELOPMENT
Advance through clinical
development and health
authority review with confidence.
ALL STAGES
Benefit from our expertise
across all phases
of drug development.
PRECLINICAL
Navigate the critical
preclinical testing phase
with expert guidance.
COMMERCIALIZATION
Successfully bring your
product to market with
our commercialization support.
ALL SERVICES
Access comprehensive
services for every stage
of product development.

ABOUT US

We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.

LEARN MORE ABOUT US
EXPERTISE WITH PERSONALITY
OUR FOUNDER
Discover the visionary
leader driving Halloran's
success and innovation.
STRATEGIC PARTNERS
Meet our trusted
strategic partners who
enhance our capabilities.
WHY HALLORAN?
Explore the unique reasons
why clients choose
Halloran for their needs.
OUR TEAM
Get to know the dedicated
professionals who make
up the Halloran team.
CAREERS
Join our dynamic team
and advance your
career with Halloran.
LEARN MORE
Find out more about
Halloran's comprehensive
services and expertise.
hcg-service-hero-1

Insights From Halloran

Halloran Consulting GroupFeb 22, 2024 12:21:00 PM9 min read

5 Broad Implications for Project Optimus: Future of Oncology Trials

Oncology drug development is different from most drug development programs in other ...
Start Reading
Halloran Consulting GroupFeb 15, 2024 12:16:00 PM8 min read

Reconsidering the 3+3 Dose Escalation in Oncology Studies

Many product developers are propelled by the goal of delivering life-saving treatments as ...
Start Reading
Rashida ChallengerFeb 15, 2024 11:45:00 AM3 min read

Trial Rescue: Leadership Approach Propels Clinical Development

Read our latest Case Study Clinical Trial Rescue: Leadership Approach to Propel Clinical ...
Start Reading
Halloran Consulting GroupJan 24, 2024 12:05:00 PM2 min read

Why The FDA Modernization Act 2.0 is The Challenge Our Industry Needs 

Shawn Roach, one of Halloran’s Regulatory Chemistry, Manufacturing, and Controls (CMC) ...
Start Reading
Rashida ChallengerJan 23, 2024 12:16:00 PM2 min read

Clinical Trial Manager to The Rescue: The Halloran Approach 

Clinical trials are essential for bringing new treatments to patients. However, not all ...
Start Reading
Jillian FarrelJan 16, 2024 11:31:00 AM6 min read

Navigating the Patient Clinical Trial Training Matrix

Content in collaboration with ScienceMedia Authors: Malachi Bierstein, Chief Commercial ...
Start Reading
Halloran Consulting GroupJan 10, 2024 12:21:00 PM4 min read

The Value of Artificial Intelligence to Support Inspection Readiness   

A Health Authority (HA) inspection of a clinical trial can occur at any time, and ...
Start Reading
Halloran Consulting GroupJan 4, 2024 11:43:00 AM3 min read

Navigating Clinical Trial Leadership Turnover

Clinical Trial Leadership—Directors, Associate Directors, and Senior Clinical Trial ...
Start Reading
Halloran Consulting GroupDec 18, 2023 1:31:00 PM4 min read

Three Key Impacts of ICH E6(R3) on RBQM and Oversight 

The International Council for Harmonisation draft guideline, ICH E6(R3), released on May ...
Start Reading
Karen TraversDec 12, 2023 3:42:00 PM1 min read

Implications of FDA’s Final Guidance on Informed Consent

Are you sponsoring a clinical trial and wondering how to develop an Informed Consent Form ...
Start Reading
Load more posts